1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1 Snippet by Procedures
3.2 Snippet by Product
3.4 Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1 Rise in Female Cosmetic Surgery Patients
4.1.1.2 Rise in the demand for minimally invasive surgical procedures
4.1.2. Restraints
4.1.2.1. High Cost of Cosmetic Surgeries
4.1.3. Opportunity
4.1.3.1The introduction of self-monitoring apps
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Procedure
7.1. Abdominoplasty
7.2. Blepharoplasty
7.3. Mammoplasty
7.4. Buttock augmentation
7.5. Laser Skin Rejuvenation
7.6. Face Surgery
7.7. Liposuction
7.8. Other
8. By Product
8.1. Implants
8.1.1. Lip Implants
8.1.2. Breast Implants
8.1.3. Buttock Implants
8.1.4. Chin and Cheek Implants
8.2. Equipment
8.2.1. Hair removal lasers
8.2.2. Dermal resurfacing lasers
8.2.3. Liposuction equipment
8.2.4. Microdermabrators
8.3. Injectables
8.3.1. Botulinum toxin
8.3.2. Collagen
8.3.3. Hyaluronic acid
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. AbbVie
11.1.1. Company overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Bausch Health Companies
11.3. Candela Syneron
11.4. Cynosure Technologies
11.5. Galderma SA
11.6. Johnson and Johnson
11.7. Merz Pharma GmbH
11.8. Sientra
11.9. Sinclair Pharma
11.10. Teoxane Laboratories
12. Appendix
12.1. About Us and Services
12.2. Contact Us